J. Dana Hughes
Originally from Boston, Massachusetts, Dana has been based in New York City since 1996. Dana Hughes is currently Vice President in Pfizer’s Worldwide Business Development group, serving as its Global Head for Integration Management and Global Head of Alliance Management. His work includes the integration of Wyeth, Hospira and most recently, Array Biopharmaceuticals. He is currently managing the separation of Upjohn, the legacy division of Pfizer, and has overseen the recent separation of Pfizer Consumer Healthcare, Hospira Infusion Systems and the creation of independent companies such as Zoetis (former Pfizer Animal Health) and Allogene (former Pfizer CAR-T portfolio).
Prior to Pfizer, Dana was a Principal in The Boston Consulting Group, focusing on the strategy and financial performance of large healthcare and information technology clients. Before this, Dana advised multi-industry businesses with Lazard Frères & Co’s mergers and acquisitions group.
Dana received his Bachelor’s of Arts in Classical Archaeology from Harvard University. After graduation, he received an ICCS Fellowship at the American Academy in Rome. He also holds an MBA in International Finance from Columbia University. He is a Board Member for the Brooklyn Bridge Conservancy.
Dana lives in Brooklyn with his wife Melissa Prober, Senior Associate Council for the New York Genome Center, and two children. Dana is on the Board of the Brooklyn Bridge Park Conservancy and is an active user of the park.
Elected to the Board: September 2020
Class Term: 2024
Term Limit: 2028